HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Research | Clinical Cancer Research |
Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 2, Issue 3 155-164, Copyright © 1991 by American Association of Cancer Research
ARTICLES |
J den Hertog, SW de Laat, J Schlessinger and W Kruijer
Hubrecht Laboratory, Netherlands Institute for Developmental Biology, Utrecht.
The human epidermal growth factor receptor (hEGF-R) was introduced into murine P19 embryonal carcinoma (EC) cells, which do not express endogenous EGF-R. Undifferentiated stable P19 EC transfectants containing multiple copies of the hEGF-R complementary DNA were isolated. These cells express functional EGF-R, exhibiting characteristic biphasic EGF binding and intrinsic tyrosine protein kinase activity. Whereas normally EGF induces the expression of multiple nuclear protooncogenes, only junB expression is induced by EGF in the HER-transfected cells. This indicates that undifferentiated P19 EC cells contain at least part of a signal transduction machinery capable of coupling to the ectopically expressed hEGF-R. Interestingly, neuronal differentiation is induced in these cells in response to EGF under culture conditions resembling those during early preimplantation embryogenesis. These results indicate that neuronal differentiation of pluripotent P19 EC cells can be induced via activation of a tyrosine protein kinase signaling pathway.
This article has been cited by other articles:
![]() |
![]() |
![]() |
![]() |
![]() ![]() A. Buist, C. Blanchetot, L. G. J. Tertoolen, and J. den Hertog Identification of p130cas as an in VivoSubstrate of Receptor Protein-tyrosine Phosphatase {alpha} J. Biol. Chem., July 7, 2000; 275(27): 20754 - 20761. [Abstract] [Full Text] [PDF] ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() ![]() O Silvennoinen, C Schindler, J Schlessinger, and D. Levy Ras-independent growth factor signaling by transcription factor tyrosine phosphorylation Science, September 24, 1993; 261(5129): 1736 - 1739. [Abstract] [PDF] ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() ![]() A. Buist, C. Blanchetot, L. G. J. Tertoolen, and J. den Hertog Identification of p130cas as an in VivoSubstrate of Receptor Protein-tyrosine Phosphatase {alpha} J. Biol. Chem., July 7, 2000; 275(27): 20754 - 20761. [Abstract] [Full Text] [PDF] ![]() |
![]() |
HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Research | Clinical Cancer Research |
Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
Molecular Cancer Research | Cell Growth & Differentiation |